Details About Generic Salt ::  Immune1

Main Medicine Class:: Immune serum   

(ih-MYOON GLAH-byoo-lin intravenous)
Gamimune N, Gammagard S/D, Gammar-P I.V., Iveegam, Polygam, Polygam S/D, Sandoglobulin, Venoglobulin-I, Venoglobulin-S,  Iveegam Immuno
Class: Immune serum

 

Drugs Class ::

 Action Replaces normal human IgG antibodies. Promotes opsonization, fixes complement, and neutralizes bacteria, viruses, fungi, and parasites, and their toxins.

Indications for Drugs ::

 Indications Treatment of primary immunodeficiency states in patients unable to produce sufficient amounts of IgG antibodies; prevention of bacterial infections in patients with hypogamma globulinemia, recurrent bacterial infections associated with B-cell chronic lymphocytic leukemia or Kawasaki disease, children with AIDS, and bone-marrow transplant patients; treatment of immune thrombocytopenia purpura. Unlabeled use(s): Chronic fatigue syndrome; quinidine-induced thrombocytopenia.

Drug Dose ::

 Route/Dosage

Immunodeficiency Syndrome

ADULTS AND CHILDREN: Gammagard: IV 200 to 400 mg/kg initially; then monthly doses of ³ 100 mg/kg are recommended.

Gammar S/D: IV Initial dose of 0.5 mL/kg/hr. Eventual: 5%: 4 mL/kg/hr; 10%: 8 mL/kg/hr.

Gammar-P: IV Initial dose: 0.6 mL/kg/hr × 15 to 30 min. Eventual: 1.2 to 3.6 mL/kg/hr.

Gammar-IV: IV Initial loading dose of ³ 200 mg/kg; then 100 to 200 mg/kg q 3 to 4 wk.

Gamimune N: IV 100 to 200 mg/kg monthly. If clinical response or level of IgG is insufficient, increase dose to 400 mg/kg or repeat infusion more frequently. Pediatric HIV infection: 400 mg (8 mL/kg) q 28 days.

Iveegam: IV 200 mg/kg monthly. If clinical response or level of IgG is insufficient, increase dose 4-fold or repeat infusion more frequently. Doses up to 800 mg/kg monthly have been tolerated.

Polygam: IV 200 to 400 mg/kg recommended initially; then 100 mg/kg monthly. Doses based on monitoring clinical response.

Polygam S/D: IV Initial: 0.5 mL/kg/hr. Eventual: 5%: 4 mL/kg/hr; 10%: 8 mL/kg/hr.

Sandoglobulin: IV 200 mg/kg monthly. If clinical response or level of IgG is insufficient, increase dose to 300 mg/kg or repeat infusion more frequently.

Venoglobulin-I: IV 200 mg/kg monthly. If clinical response or level of IgG is insufficient, increase dose to 300 to 400 mg/kg or repeat infusion more frequently.

Immune Thrombocytopenic Purpura

ADULTS AND CHILDREN: Gammagard: IV 1000 mg/kg. Give up to 3 doses on alternate days if required, based on clinical response and platelet count.

Gammagard S/D: IV Initial dose of 0.5 ml/kg/hr. Eventual: 5%: 4 mL/kg/hr; 10%: 8 mL/kg/hr.

Gamimune N: IV 400 mg/kg for 5 consecutive days.

Polygam: IV 1000 mg/kg recommended initially; then additional doses determined by clinical response and platelet count. Up to 3 doses may be given on alternate days if needed.

Polygam S/D: IV Initial: 0.5 mL/kg/hr. Eventual: 5%: 4 mL/kg/hr; 10%: 8 mL/kg/hr.

Sandoglobulin: IV 400 mg/kg for 2 to 5 consecutive days.

Venoglobulin-I: IV Induction: 500 mg/kg/day for 2 to 7 consecutive days. Patients responding to induction therapy by manifesting platelet count of 30,000 to 50,000/mm3 may be discontinued after 2 to 7 daily doses. Maintenance: If platelet count falls below 30,000/mm3 or patient manifests significant bleeding, infuse 500 to 2000 mg/kg as single dose q 2 wk or less as needed to maintain platelet count above 30,000/mm3 in children and 20,000/mm3 in adults.

B-Cell Chronic Lymphocytic Leukemia

ADULTS AND CHILDREN: Gammagard: IV 400 mg/kg q 3 to 4 wk.

Polygam: IV 400 mg/kg q 3 to 4 wk.

Contraindication ::

 Contraindications Immediate hypersensitivity to human antibody product; circulating anti-IgA antibodies; possible aseptic meningitis syndrome.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Renal: Has been associated with renal dysfunction, acute renal failure, osmotic nephrosis, and death. Hypersensitivity: Hypersensitivity, including anaphylaxis, may occur.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

CV: Palpitations; hypotension; hypertension. CNS: Anxiety; dizziness; headache. GI: Nausea; vomiting; abdominal cramps. RESP: Shortness of breath; wheezing. OTHER: Pallor; cyanosis; immediate anaphylactic and hypersensitivity reactions; back pain; chills; muscle or joint pain; arthralgia; malaise; flushing; chest tightness.

Drug Mode of Action ::  

 Action Replaces normal human IgG antibodies. Promotes opsonization, fixes complement, and neutralizes bacteria, viruses, fungi, and parasites, and their toxins.

Drug Interactions ::

 Interactions

Live vaccines: To avoid inactivating vaccines containing live viruses or bacteria, give live vaccines 2 to 4 wk before or 3 to 11 mo after IGIV depending on dose. INCOMPATIBILITIES: Admixture: Do not mix IGIV with other medications.

Drug Assesment ::

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Keep epinephrine (1:1000) and resuscitation equipment readily available.
  • Monitor vital signs continuously and observe for adverse symptoms (eg, anaphylaxis, fever, chills, nausea, vomiting) throughout infusion.
  • If adverse reactions such as fever, chills, nausea, or vomiting develop, slowing infusion rate will usually eliminate reaction.

Drug Storage/Management ::

 Administration/Storage

  • Administer via IV infusion only. Use separate IV line and electronic infusion device.
  • Proceed with infusion only if reconstituted solution is clear and is at approximate body temperature.
  • Store Gamimune N and Iveegam in refrigerator.
  • Store Sandoglobulin, Gammagard S/D, Gammar-P, Polygam S/D, and Venoglobulin-I at room temperature.
  • Discard any unused solution.
  • Avoid freezing. Do not use solution that has been frozen.

Drug Notes ::

 Patient/Family Education

  • Instruct patient to notify physician immediately of nausea, chills, shortness of breath, headache, and chest tightness during infusion.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.